Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03247608 · ClinicalTrials.gov registry record · NA
ConnectedHeartHealth - Heart Failure Readmission Intervention
A NA study, sponsored by LifeBridge Health.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03247608: Completed NA study, sponsored by LifeBridge Health.
NCT03247608 is a NA study that has completed, run by LifeBridge Health. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03247608, a NA study, has completed, sponsored by LifeBridge Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a single-center, pilot study that will evaluate the effectiveness of the AHA science based CarePlans and the Ambio Health technology in improving the risk adjusted 30 day readmissions rate, patient compliance, and biometrics. The study will also be used to assess the feasibility of similar heart failure transition programs in the future.
Primary Outcome
The primary endpoint will be the risk adjusted 30 day readmissions rate of the study population in comparison with the Sinai Hospital and the National Average.
Interventions
- BEHAVIORAL Ambio Health Remote Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-10-09 |
| Phase | NA |
What the finished NCT03247608 record still lists
NCT03247608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Ambio Health Remote Monitoring is the first listed.
NCT03247608 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03247608 about?
NCT03247608 is a clinical study titled "ConnectedHeartHealth - Heart Failure Readmission Intervention". This is a single-center, pilot study that will evaluate the effectiveness of the AHA science based CarePlans and the Ambio Health technology in improving the risk adjusted 30 day readmissions rate, patient compliance, and biometrics. The study will also be used to assess the feasibility of similar h...
What is the current status of trial NCT03247608?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-11. Estimated completion is 2017-10-09.
What interventions are being tested in trial NCT03247608?
The interventions under investigation include: Ambio Health Remote Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT03247608?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03247608's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia